We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 1760I
GlaxoSmithKline PLC
12 April 2022
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Ms E Walmsley ==== ===================================== ================================================= b) Position/status Chief Executive Officer ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 32 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Mr R Connor ==== ===================================== ================================================= b) Position/status President, Vaccines and Global Health ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 91 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Ms D Conrad ==== ===================================== ================================================= b) Position/status Chief People Officer ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 6 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA')
==== ========================================================================================= a) Name Mr J Ford ==== ====================================== ================================================= b) Position/status SVP and Group General Counsel, Legal and Compliance ==== ====================================== ================================================= c) Initial notification/ Initial notification amendment ==== ====================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================= a) Name GlaxoSmithKline plc ==== ====================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ====================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================= =================== GBP17.3554 5 ===================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================== ========================== e) Date of the transaction 2022-04-07 ==== ====================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Ms S Jackson ==== ===================================== ================================================= b) Position/status SVP, Global Communications and CEO Office ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 84 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr D Jackson ==== ===================================== ===================================================== b) Position/status PCA of Ms S Jackson (SVP, Global Communications and CEO Office) ==== ===================================== ===================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ===================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ===================================== ===================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ===================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ===================================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ===================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== ===================== GBP 17.3554 33 ====================================================================== ===================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price =================================================================== ============================ e) Date of the transaction 2022-04-07 ==== ===================================== ===================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ===================================================== 1. Details of PDMR/person closely associated with them ('PCA')
==== ======================================================================================== a) Name Mr L Miels ==== ===================================== ================================================= b) Position/status Chief Commercial Officer ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 4 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Mr D Redfern ==== ===================================== ================================================= b) Position/status Chief Strategy Officer ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 101 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Mr R Simard ==== ===================================== ================================================= b) Position/status President, Pharmaceuticals Supply Chain ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 33 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Mr P Thomson ==== ===================================== =================================================
b) Position/status President, Global Affairs ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 61 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Ms D Waterhouse ==== ===================================== ================================================= b) Position/status CEO, ViiV Healthcare ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 82 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ================================================= 1. Details of PDMR/person closely associated with them ('PCA') ==== ======================================================================================== a) Name Ms V Whyte ==== ===================================== ================================================= b) Position/status Company Secretary ==== ===================================== ================================================= c) Initial notification/ Initial notification amendment ==== ===================================== ================================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ======================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ================================================= b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ================================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ======================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ================================================= b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 7 April 2022, on shares held through the Company's Share Reward Plan. ==== ===================================== ================================================= c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ========================= =================== GBP 17.3554 75 ==================================================================== =================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================= ========================== e) Date of the transaction 2022-04-07 ==== ===================================== ================================================= f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== =================================================, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQLLFFLZLBBBD
(END) Dow Jones Newswires
April 12, 2022 12:10 ET (16:10 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions